What is the current annual EBITDA of MCK?

As of today, MCK annual EBITDA is $5.01B

What is 1-year change in MCK annual EBITDA?

MCK annual EBITDA is up +9.78% year-over-year

What is 3-year change in MCK annual EBITDA?

MCK annual EBITDA is up +34.48% over the past 3 years

How far is MCK annual EBITDA from its all-time high?

MCK annual EBITDA is currently -5.69% below its historical high of $5.31B set on March 31, 2023

How does MCK annual EBITDA rank versus sector peers?

MCK annual EBITDA is higher than 97.79% of companies in Healthcare sector

When is MCK next annual earnings release?

As of today, the next annual earnings release for MCK has not been scheduled

What is the current quarterly EBITDA of MCK?

As of today, MCK quarterly EBITDA is $1.66B

What is MCK quarterly EBITDA most recent change?

MCK quarterly EBITDA was up +34.42% on September 30, 2025

What is 1-year change in MCK quarterly EBITDA?

MCK quarterly EBITDA is up +82.38% year-over-year

How far is MCK quarterly EBITDA from its all-time high?

MCK quarterly EBITDA is currently -48.98% below its historical high of $3.25B set on June 30, 1994

How does MCK quarterly EBITDA rank versus sector peers?

MCK quarterly EBITDA is higher than 97.83% of companies in Healthcare sector

When is MCK next earnings release?

The next earnings release for MCK is on February 4, 2026

What is the current TTM EBITDA of MCK?

As of today, MCK TTM EBITDA is $5.52B

What is MCK TTM EBITDA most recent change?

MCK TTM EBITDA was up +15.69% on September 30, 2025

What is 1-year change in MCK TTM EBITDA?

MCK TTM EBITDA is up +23.88% year-over-year

How far is MCK TTM EBITDA from its all-time high?

MCK TTM EBITDA is currently -15.04% below its historical high of $6.49B set on September 30, 1994

How does MCK TTM EBITDA rank versus sector peers?

MCK TTM EBITDA is higher than 97.83% of companies in Healthcare sector

When is MCK next earnings release?

The next earnings release for MCK is on February 4, 2026

MCK EBITDA History & Chart Since 1980

Annual EBITDA

$5.01B$446.00M+9.78%

March 31, 2025

Summary

Current Value: As of today, MCK annual EBITDA is $5.01B, up +9.78% on March 31, 2025
Historical Performance: MCK annual EBITDA is up +34.48% over the past 3 years, and up +27.30% over the past 5 years
All-Time High Comparison: MCK annual EBITDA is currently -5.69% below its historical high of $5.31B set on March 31, 2023
3-Year Low Comparison: MCK annual EBITDA is +34.48% above its 3-year low of $3.72B reached on an earlier date
Sector Comparison: MCK annual EBITDA is higher than 97.79% of companies in Healthcare sector

EBITDA Chart

Add series to chart

Add series to chart1/6

Company, ETF, index, screener or watchlist

Series

Performance

MCK Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Mar 31, 25	$5.01B	+9.8%	+34.5%	+27.3%	+101.6%
Quarterly EBITDA	Sep 30, 25	$1.66B	+82.4%	+21.9%	+48.5%	+162.4%
TTM EBITDA	Sep 30, 25	$5.52B	+23.9%	+31.9%	+30.5%	+120.1%
Price	Jan 16, 26	$840.46	+41.2%	+120.1%	+355.7%	+1033.2%
PE Ratio	Jan 16, 26	26.17	-4.1%	+49.5%	–	+39.0%
Annual Revenue	Mar 31, 25	$359.05B	+16.2%	+36.0%	+55.4%	+230.3%
Annual EPS	Mar 31, 25	$25.72	+14.9%	+255.8%	+420.2%	+456.0%
Annual EBIT	Mar 31, 25	$4.37B	+11.3%	+60.6%	+45.1%	+117.5%
Annual Net Income	Mar 31, 25	$3.48B	+10.2%	+169.4%	+209.2%	+175.6%

EBITDA Highs

MCK Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$5.31B	Mar 31, 23	-5.7%
5Y	$5.31B	Mar 31, 23	-5.7%
All	$5.31B	Mar 31, 23	-5.7%

EBITDA Lows

MCK Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$3.72B	N/A	+34.5%
5Y	$3.72B	Mar 31, 22	+34.5%
All	$39.70M	Mar 31, 95	>+9999.0%

EBITDA History

Year	Value	Change
2025	$5.01B	+9.8%
2024	$4.56B	-14.1%
2023	$5.31B	+42.6%
2022	$3.72B	-21.3%
2021	$4.73B	+20.3%
2020	$3.93B	-2.3%
2019	$4.03B	+4.0%
2018	$3.87B	-9.3%
2017	$4.27B	-9.9%
2016	$4.74B	+4.1%
2015	$4.55B	+35.6%
2014	$3.35B	+11.4%
2013	$3.01B	+2.7%
2012	$2.93B	+13.0%
2011	$2.59B	+4.4%
2010	$2.48B	+14.8%
2009	$2.16B	+17.0%
2008	$1.85B	+17.1%
2007	$1.58B	+10.2%
2006	$1.43B	+14.3%
2005	$1.25B	+3.2%
2004	$1.22B	+7.2%
2003	$1.13B	+16.1%

Year	Value	Change
2002	$976.20M	+150.9%
2001	$389.10M	-31.8%
2000	$570.50M	+7.3%
1999	$531.50M	+18.3%
1998	$449.40M	+173.0%
1997	$164.60M	-46.1%
1996	$305.50M	+669.5%
1995	$39.70M	-89.0%
1994	$360.00M	+11.2%
1993	$323.80M	+6.6%
1992	$303.70M	+0.2%
1991	$303.10M	+3.9%
1990	$291.60M	+5.9%
1989	$275.30M	-2.2%
1988	$281.40M	+30.8%
1987	$215.20M	-13.7%
1986	$249.50M	+30.3%
1985	$191.51M	+23.7%
1984	$154.76M	-14.7%
1983	$181.40M	+7.9%
1982	$168.11M	+14.5%
1981	$146.85M	+17.4%
1980	$125.08M	-

FAQ

What is the current annual EBITDA of MCK?
As of today, MCK annual EBITDA is $5.01B
What is 1-year change in MCK annual EBITDA?
MCK annual EBITDA is up +9.78% year-over-year
What is 3-year change in MCK annual EBITDA?
MCK annual EBITDA is up +34.48% over the past 3 years
How far is MCK annual EBITDA from its all-time high?
MCK annual EBITDA is currently -5.69% below its historical high of $5.31B set on March 31, 2023
How does MCK annual EBITDA rank versus sector peers?
MCK annual EBITDA is higher than 97.79% of companies in Healthcare sector
When is MCK next annual earnings release?
As of today, the next annual earnings release for MCK has not been scheduled

Quarterly EBITDA

$1.66B$424.00M+34.42%

September 30, 2025

Summary

Current Value: As of today, MCK quarterly EBITDA is $1.66B, up +34.42% on September 30, 2025
Historical Performance: MCK quarterly EBITDA is up +82.38% year-over-year, and up +21.85% over the past 3 years
All-Time High Comparison: MCK quarterly EBITDA is currently -48.98% below its historical high of $3.25B set on June 30, 1994
3-Year Low Comparison: MCK quarterly EBITDA is +111.76% above its 3-year low of $782.00M reached on December 31, 2023
Sector Comparison: MCK quarterly EBITDA is higher than 97.83% of companies in Healthcare sector

Performance

MCK Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Sep 30, 25	$1.66B	+34.4%	+82.4%	+21.9%	+48.5%
Annual EBITDA	Mar 31, 25	$5.01B	–	+9.8%	+34.5%	+27.3%
TTM EBITDA	Sep 30, 25	$5.52B	+15.7%	+23.9%	+31.9%	+30.5%
Price	Jan 16, 26	$840.46	+8.4%	+41.2%	+120.1%	+355.7%
PE Ratio	Jan 16, 26	26.17	+8.4%	-4.1%	+49.5%	–
Quarterly Revenue	Sep 30, 25	$103.15B	+5.4%	+10.1%	+47.0%	+69.6%
Quarterly EPS	Sep 30, 25	$8.92	+42.8%	+378.7%	+38.9%	+152.1%
Quarterly EBIT	Sep 30, 25	$1.47B	+36.6%	+97.0%	+28.2%	+82.6%
Quarterly Net Income	Sep 30, 25	$1.16B	+40.0%	+305.2%	+19.5%	+85.5%

Quarterly EBITDA Highs

MCK Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$1.66B	Sep 30, 25	at high
3Y	$1.66B	Sep 30, 25	at high
5Y	$1.66B	Sep 30, 25	at high
All	$3.25B	Jun 30, 94	-49.0%

Quarterly EBITDA Lows

MCK Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$1.19B	Mar 31, 25	+39.5%
3Y	$782.00M	Dec 31, 23	+111.8%
5Y	$554.00M	Dec 31, 21	+198.9%
All	-$216.20M	Dec 31, 94	+866.0%

Quarterly EBITDA History

Month	Value	Change
Sep 2025	$1.66B	+34.4%
Jun 2025	$1.23B	+3.8%
Mar 2025	$1.19B	-17.6%
Dec 2024	$1.44B	+58.6%
Sep 2024	$908.00M	-26.2%
Jun 2024	$1.23B	-19.7%
Mar 2024	$1.53B	+95.9%
Dec 2023	$782.00M	-25.9%
Sep 2023	$1.06B	-11.6%
Jun 2023	$1.19B	-10.2%
Mar 2023	$1.33B	-1.3%
Dec 2022	$1.35B	-0.9%
Sep 2022	$1.36B	+6.6%
Jun 2022	$1.28B	+28.5%
Mar 2022	$992.00M	+79.1%
Dec 2021	$554.00M	-41.1%
Sep 2021	$940.00M	-15.2%
Jun 2021	$1.11B	-20.8%
Mar 2021	$1.40B	+15.3%
Dec 2020	$1.21B	+8.8%
Sep 2020	$1.12B	+17.9%
Jun 2020	$946.00M	-34.3%
Mar 2020	$1.44B	+98.2%
Dec 2019	$726.00M	-19.8%
Sep 2019	$905.00M	+2.1%
Jun 2019	$886.00M	-20.8%
Mar 2019	$1.12B	+17.8%
Dec 2018	$949.00M	-6.1%
Sep 2018	$1.01B	+18.7%
Jun 2018	$852.00M	-15.9%
Mar 2018	$1.01B	+5.0%
Dec 2017	$965.00M	-9.0%
Sep 2017	$1.06B	+27.5%
Jun 2017	$832.00M	-13.2%
Mar 2017	$959.00M	-13.7%
Dec 2016	$1.11B	-0.2%
Sep 2016	$1.11B	+3.6%
Jun 2016	$1.07B	-6.2%
Mar 2016	$1.15B	-3.5%
Dec 2015	$1.19B	+3.9%
Sep 2015	$1.14B	-7.5%
Jun 2015	$1.24B	-1.3%
Mar 2015	$1.25B	+13.2%
Dec 2014	$1.11B	-3.0%
Sep 2014	$1.14B	+11.6%
Jun 2014	$1.02B	-23.2%
Mar 2014	$1.33B	+81.7%
Dec 2013	$732.00M	-17.7%
Sep 2013	$889.00M	+7.2%
Jun 2013	$829.00M	-8.0%
Mar 2013	$901.00M	+33.9%
Dec 2012	$673.00M	-13.8%
Sep 2012	$781.00M	+19.1%
Jun 2012	$656.00M	-24.4%
Mar 2012	$868.00M	+24.4%
Dec 2011	$698.00M	-5.7%
Sep 2011	$740.00M	+19.9%
Jun 2011	$617.00M	-19.6%
Mar 2011	$767.00M	+25.7%
Dec 2010	$610.00M	-3.3%
Sep 2010	$631.00M	+16.2%
Jun 2010	$543.00M	-22.1%
Mar 2010	$697.00M	+9.8%

Month	Value	Change
Dec 2009	$635.00M	+13.4%
Sep 2009	$560.00M	-1.8%
Jun 2009	$570.00M	-10.2%
Mar 2009	$635.00M	+15.7%
Dec 2008	$549.00M	+11.4%
Sep 2008	$493.00M	+3.4%
Jun 2008	$477.00M	-17.2%
Mar 2008	$576.00M	+38.5%
Dec 2007	$416.00M	-6.1%
Sep 2007	$443.00M	+2.8%
Jun 2007	$431.00M	-7.3%
Mar 2007	$465.00M	+2.4%
Dec 2006	$454.00M	+26.1%
Sep 2006	$360.00M	-0.3%
Jun 2006	$361.00M	-40.6%
Mar 2006	$608.00M	+61.7%
Dec 2005	$376.00M	+28.8%
Sep 2005	$292.00M	-10.4%
Jun 2005	$326.00M	-27.4%
Mar 2005	$449.00M	+52.2%
Dec 2004	$295.00M	+56.1%
Sep 2004	$189.00M	-41.1%
Jun 2004	$321.00M	-17.2%
Mar 2004	$387.70M	+67.3%
Dec 2003	$231.80M	-27.5%
Sep 2003	$319.70M	+7.8%
Jun 2003	$296.60M	-14.9%
Mar 2003	$348.50M	+34.1%
Dec 2002	$259.80M	+0.5%
Sep 2002	$258.60M	+1.6%
Jun 2002	$254.50M	-0.9%
Mar 2002	$256.70M	-9.1%
Dec 2001	$282.40M	+81.8%
Sep 2001	$155.30M	-26.2%
Jun 2001	$210.40M	+205.6%
Mar 2001	-$199.20M	-196.8%
Dec 2000	$205.70M	+7.9%
Sep 2000	$190.70M	-0.6%
Jun 2000	$191.90M	+120.8%
Mar 2000	$86.90M	+21.9%
Dec 1999	$71.30M	-66.7%
Sep 1999	$214.20M	+4.1%
Jun 1999	$205.80M	+99.8%
Mar 1999	$103.00M	-33.2%
Dec 1998	$154.10M	+116.7%
Sep 1998	$71.10M	-42.3%
Jun 1998	$123.20M	+9.7%
Mar 1998	$112.30M	-4.6%
Dec 1997	$117.70M	+5.3%
Sep 1997	$111.80M	+3.9%
Jun 1997	$107.60M	-65.3%
Mar 1997	$309.90M	+475.2%
Dec 1996	-$82.60M	-201.7%
Sep 1996	$81.20M	+241.2%
Jun 1996	$23.80M	-52.5%
Mar 1996	$50.10M	-40.6%
Dec 1995	$84.30M	+0.1%
Sep 1995	$84.20M	-3.1%
Jun 1995	$86.90M	-23.4%
Mar 1995	$113.50M	+152.5%
Dec 1994	-$216.20M	-106.7%
Sep 1994	$3.25B	0.0%
Jun 1994	$3.25B	-

FAQ

What is the current quarterly EBITDA of MCK?
As of today, MCK quarterly EBITDA is $1.66B
What is MCK quarterly EBITDA most recent change?
MCK quarterly EBITDA was up +34.42% on September 30, 2025
What is 1-year change in MCK quarterly EBITDA?
MCK quarterly EBITDA is up +82.38% year-over-year
How far is MCK quarterly EBITDA from its all-time high?
MCK quarterly EBITDA is currently -48.98% below its historical high of $3.25B set on June 30, 1994
How does MCK quarterly EBITDA rank versus sector peers?
MCK quarterly EBITDA is higher than 97.83% of companies in Healthcare sector
When is MCK next earnings release?
The next earnings release for MCK is on February 4, 2026

TTM EBITDA

$5.52B$748.00M+15.69%

September 30, 2025

Summary

Current Value: As of today, MCK TTM EBITDA is $5.52B, up +15.69% on September 30, 2025
Historical Performance: MCK TTM EBITDA is up +23.88% year-over-year, and up +31.94% over the past 3 years
All-Time High Comparison: MCK TTM EBITDA is currently -15.04% below its historical high of $6.49B set on September 30, 1994
3-Year Low Comparison: MCK TTM EBITDA is +26.52% above its 3-year low of $4.36B reached on December 31, 2023
Sector Comparison: MCK TTM EBITDA is higher than 97.83% of companies in Healthcare sector

Performance

MCK Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Sep 30, 25	$5.52B	+15.7%	+23.9%	+31.9%	+30.5%
Annual EBITDA	Mar 31, 25	$5.01B	–	+9.8%	+34.5%	+27.3%
Quarterly EBITDA	Sep 30, 25	$1.66B	+34.4%	+82.4%	+21.9%	+48.5%
Price	Jan 16, 26	$840.46	+8.4%	+41.2%	+120.1%	+355.7%
PE Ratio	Jan 16, 26	26.17	+8.4%	-4.1%	+49.5%	–
TTM Revenue	Sep 30, 25	$387.09B	+2.5%	+17.2%	+42.3%	+65.3%
TTM EPS	Sep 30, 25	$32.12	+28.2%	+66.5%	+127.6%	+144.0%
TTM EBIT	Sep 30, 25	$4.87B	+17.4%	+28.0%	+46.6%	+54.2%
TTM Net Income	Sep 30, 25	$4.23B	+26.1%	+56.2%	+89.9%	+73.2%

TTM EBITDA Highs

MCK TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$5.52B	Sep 30, 25	at high
3Y	$5.52B	Sep 30, 25	at high
5Y	$5.52B	Sep 30, 25	at high
All	$6.49B	Sep 30, 94	-15.0%

TTM EBITDA Lows

MCK TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$4.77B	Mar 31, 25	+15.7%
3Y	$4.36B	Dec 31, 23	+26.5%
5Y	$3.59B	Mar 31, 22	+53.5%
All	$68.40M	Sep 30, 95	+7962.9%

TTM EBITDA History

Month	Value	Change
Sep 2025	$5.52B	+15.7%
Jun 2025	$4.77B	+0.0%
Mar 2025	$4.77B	-6.8%
Dec 2024	$5.11B	+14.8%
Sep 2024	$4.45B	-3.2%
Jun 2024	$4.60B	+0.8%
Mar 2024	$4.56B	+4.7%
Dec 2023	$4.36B	-11.5%
Sep 2023	$4.92B	-5.8%
Jun 2023	$5.23B	-1.5%
Mar 2023	$5.31B	+6.8%
Dec 2022	$4.97B	+19.0%
Sep 2022	$4.18B	+11.1%
Jun 2022	$3.76B	+4.6%
Mar 2022	$3.59B	-10.2%
Dec 2021	$4.00B	-14.1%
Sep 2021	$4.66B	-3.6%
Jun 2021	$4.84B	+3.5%
Mar 2021	$4.67B	-0.8%
Dec 2020	$4.71B	+11.5%
Sep 2020	$4.23B	+5.2%
Jun 2020	$4.02B	+1.5%
Mar 2020	$3.96B	+8.8%
Dec 2019	$3.64B	-5.8%
Sep 2019	$3.86B	-2.7%
Jun 2019	$3.96B	+0.9%
Mar 2019	$3.93B	+2.7%
Dec 2018	$3.83B	-0.4%
Sep 2018	$3.84B	-1.3%
Jun 2018	$3.89B	+0.5%
Mar 2018	$3.87B	+1.4%
Dec 2017	$3.82B	-3.7%
Sep 2017	$3.96B	-1.3%
Jun 2017	$4.02B	-5.7%
Mar 2017	$4.26B	-4.2%
Dec 2016	$4.44B	-1.7%
Sep 2016	$4.52B	-0.6%
Jun 2016	$4.55B	-3.4%
Mar 2016	$4.71B	-2.2%
Dec 2015	$4.82B	+1.7%
Sep 2015	$4.73B	+0.1%
Jun 2015	$4.73B	+4.7%
Mar 2015	$4.52B	-1.7%
Dec 2014	$4.60B	+8.8%
Sep 2014	$4.22B	+6.3%
Jun 2014	$3.97B	+5.1%
Mar 2014	$3.78B	+12.8%
Dec 2013	$3.35B	+1.8%
Sep 2013	$3.29B	+3.4%
Jun 2013	$3.18B	+5.7%
Mar 2013	$3.01B	+1.1%
Dec 2012	$2.98B	-0.8%
Sep 2012	$3.00B	+1.4%
Jun 2012	$2.96B	+1.3%
Mar 2012	$2.92B	+3.6%
Dec 2011	$2.82B	+3.2%
Sep 2011	$2.73B	+4.2%
Jun 2011	$2.63B	+2.9%
Mar 2011	$2.55B	+2.8%
Dec 2010	$2.48B	-1.0%
Sep 2010	$2.51B	+2.9%
Jun 2010	$2.44B	-1.1%
Mar 2010	$2.46B	+2.6%

Month	Value	Change
Dec 2009	$2.40B	+3.7%
Sep 2009	$2.31B	+3.0%
Jun 2009	$2.25B	+4.3%
Mar 2009	$2.15B	+2.8%
Dec 2008	$2.10B	+6.8%
Sep 2008	$1.96B	+2.6%
Jun 2008	$1.91B	+2.5%
Mar 2008	$1.87B	+6.3%
Dec 2007	$1.76B	-2.1%
Sep 2007	$1.79B	+4.9%
Jun 2007	$1.71B	+4.3%
Mar 2007	$1.64B	-8.0%
Dec 2006	$1.78B	+4.6%
Sep 2006	$1.71B	+4.2%
Jun 2006	$1.64B	+2.2%
Mar 2006	$1.60B	+11.0%
Dec 2005	$1.44B	+5.9%
Sep 2005	$1.36B	+8.2%
Jun 2005	$1.26B	+0.4%
Mar 2005	$1.25B	+5.1%
Dec 2004	$1.19B	+5.6%
Sep 2004	$1.13B	-10.4%
Jun 2004	$1.26B	+2.0%
Mar 2004	$1.24B	+3.3%
Dec 2003	$1.20B	-2.3%
Sep 2003	$1.22B	+5.3%
Jun 2003	$1.16B	+3.8%
Mar 2003	$1.12B	+8.9%
Dec 2002	$1.03B	-2.1%
Sep 2002	$1.05B	+10.9%
Jun 2002	$948.90M	+4.9%
Mar 2002	$904.80M	+101.6%
Dec 2001	$448.90M	+20.6%
Sep 2001	$372.20M	-8.7%
Jun 2001	$407.60M	+4.8%
Mar 2001	$389.10M	-42.4%
Dec 2000	$675.20M	+24.9%
Sep 2000	$540.80M	-4.2%
Jun 2000	$564.30M	-2.4%
Mar 2000	$578.20M	-2.7%
Dec 1999	$594.30M	-12.2%
Sep 1999	$677.10M	+26.8%
Jun 1999	$534.00M	+18.3%
Mar 1999	$451.40M	-2.0%
Dec 1998	$460.70M	+8.6%
Sep 1998	$424.30M	-8.8%
Jun 1998	$465.00M	+3.5%
Mar 1998	$449.40M	-30.5%
Dec 1997	$647.00M	+44.8%
Sep 1997	$446.70M	+7.4%
Jun 1997	$416.10M	+25.2%
Mar 1997	$332.30M	+358.3%
Dec 1996	$72.50M	-69.7%
Sep 1996	$239.40M	-1.2%
Jun 1996	$242.40M	-20.7%
Mar 1996	$305.50M	-17.2%
Dec 1995	$368.90M	+439.3%
Sep 1995	$68.40M	-97.9%
Jun 1995	$3.23B	-49.4%
Mar 1995	$6.39B	+1.8%
Dec 1994	$6.27B	-3.3%
Sep 1994	$6.49B	+100.0%
Jun 1994	$3.25B	-

FAQ

What is the current TTM EBITDA of MCK?
As of today, MCK TTM EBITDA is $5.52B
What is MCK TTM EBITDA most recent change?
MCK TTM EBITDA was up +15.69% on September 30, 2025
What is 1-year change in MCK TTM EBITDA?
MCK TTM EBITDA is up +23.88% year-over-year
How far is MCK TTM EBITDA from its all-time high?
MCK TTM EBITDA is currently -15.04% below its historical high of $6.49B set on September 30, 1994
How does MCK TTM EBITDA rank versus sector peers?
MCK TTM EBITDA is higher than 97.83% of companies in Healthcare sector
When is MCK next earnings release?
The next earnings release for MCK is on February 4, 2026

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

MCK Official Website www.mckesson.com
Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/927653/000092765325000140/0000927653-25-000140-index.htm
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/927653/000092765325000036/0000927653-25-000036-index.htm
MCK Profile on Yahoo Finance finance.yahoo.com/quote/MCK
MCK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mck